FHM VI, L.P. 4
4 · Allena Pharmaceuticals, Inc. · Filed Nov 6, 2017
Insider Transaction Report
Form 4
FHM VI, L.L.C.
10% Owner
Transactions
- Conversion
Common Stock
2017-11-06+2,830,373→ 2,830,373 total(indirect: By Frazier Healthcare VI, L.P.) - Purchase
Common Stock
2017-11-06$14.00/sh+500,000$7,000,000→ 3,330,373 total(indirect: By Frazier Healthcare VI, L.P.) - Conversion
Series A Preferred Stock
2017-11-06−6,122,448→ 0 total(indirect: By Frazier Healthcare VI, L.P.)→ Common Stock (1,466,805 underlying) - Conversion
Series B Preferred Stock
2017-11-06−4,629,630→ 0 total(indirect: By Frazier Healthcare VI, L.P.)→ Common Stock (1,109,159 underlying) - Conversion
Series C Preferred Stock
2017-11-06−1,061,904→ 0 total(indirect: By Frazier Healthcare VI, L.P.)→ Common Stock (254,409 underlying)
Footnotes (5)
- [F1]The Series A Preferred Stock automatically converted into Common Stock of the Issuer on a 4.174-to-1 basis upon closing of the initial public offering of the Issuer.
- [F2]The Series B Preferred Stock automatically converted into Common Stock of the Issuer on a 4.174-to-1 basis upon closing of the initial public offering of the Issuer.
- [F3]The Series C Preferred Stock automatically converted into Common Stock of the Issuer on a 4.174-to-1 basis upon closing of the initial public offering of the Issuer.
- [F4]The securities are held by Frazier Healthcare VI, L.P. ("Frazier VI"). FHM VI, L.P. ("FHM LP") is the general partner of Frazier VI and FHM VI, L.L.C. ("FHM LLC") is the general partner of FHM LP. Each of FHM LLC and FHM LP disclaims beneficial ownership of all shares held by Frazier VI except to the extent, if any, of such entity's, as applicable, pecuniary interest therein.
- [F5]Not applicable.